Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of topical RSS0393 ointment in adults with chronic plaque psoriasis
CTR20251110Phase 2Active
- Sponsor
- Reistone Biopharma
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RSS0393 in plaque psoriasis, psoriasis, sponsored by Reistone Biopharma. Started Apr 2025; status: active.
02
Drugs
RSS0393
03
Conditions
plaque psoriasispsoriasis
Beyond the preview
Go deeper on CTR20251110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251110.